Cardinal Health (CAH) Gains from Investment Securities (2009 - 2026)

Cardinal Health has disclosed Gains from Investment Securities across 18 years of filings, most recently posting -$15.0 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at -$15.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $426.0 million (up 10750.0% YoY), and the FY2025 annual result was $444.0 million, up 22300.0% from the prior year.
• Gains from Investment Securities came in at -$15.0 million for Q1 2026 at Cardinal Health, down from -$10.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $446.0 million in Q2 2025 to a low of -$15.0 million in Q1 2026.
• The 5-year median for Gains from Investment Securities is $1.0 million (2022), against an average of $58.4 million.
• Peak annual rise in Gains from Investment Securities reached 22400.0% in 2025, while the deepest fall reached 233.33% in 2025.
• Cardinal Health's Gains from Investment Securities stood at $5.0 million in 2022, then jumped by 3020.0% to $156.0 million in 2023, then tumbled by 101.92% to -$3.0 million in 2024, then slumped by 233.33% to -$10.0 million in 2025, then slumped by 50.0% to -$15.0 million in 2026.
• The last three Gains from Investment Securities figures came in at -$15.0 million (Q1 2026), -$10.0 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.